| Filed On | Filing |
|---|---|
| 01 Sep 2023 |
8-K/A: Submission of Matters to a Vote of Security Holders
On May 2, 2023, Abbott filed a Current Report on Form 8-K summarizing the matters voted on at its Annual Meeting of Shareholders held on April 28, 2023 (the “Original Report”). This amendment corrects the number of shares cast against Mi... |
| 09 Jun 2023 |
8-K/A: Submission of Matters to a Vote of Security Holders
On May 2, 2023, Abbott filed a Current Report on Form 8-K summarizing the matters voted on at its Annual Meeting of Shareholders held on April 28, 2023 (the “May 2, 2023 Form 8-K”). |
| 20 Jun 2017 |
8-K/A: Submission of Matters to a Vote of Security Holders
On May 3, 2017 Abbott filed a Form 8-K summarizing the matters voted on at its Annual Meeting of Shareholders held on April 28, 2017 (the “May 3, 2017 Form 8-K”). |
| 21 Feb 2017 |
8-K/A: Completion of Acquisition or Disposition of Assets
QuickLinks -- Click here to rapidly navigate through this document |
| 05 Mar 2015 |
8-K/A: Completion of Acquisition or Disposition of Assets
On February 27, 2015, Abbott Laboratories (“Abbott”) completed the sale of its developed markets branded generics pharmaceuticals business (“Business”) to Mylan in exchange for 110 million ordinary shares of Mylan N.V. |
| 24 Feb 2014 |
8-K/A: Changes in Registrant's Certifying Accountant
We have read Item 4 of Abbott Laboratories’ Form 8-K/A dated February 21, 2014, and have the following comments: |
| 01 Jun 2012 |
8-K/A: Departure/Election of Directors or Officers; Compensation
Effective June 1, 2012, Brian J. Blaser is Abbott’s Executive Vice President, Diagnostic Products, replacing Edward L. Michael, whose previously-announced retirement will be effective June 30, 2012. |
| 16 Jun 2011 |
8-K/A: Submission of Matters to a Vote of Security Holders
On May 5, 2011 Abbott filed a Form 8-K summarizing the matters voted on at its Annual Meeting of Shareholders held on April 29, 2011 (the “May 5, 2011 Form 8-K”). |
| 31 Jan 2005 |
8-K/A: Departure/Election of Directors or Officers; Compensation
On January 25, 2005, William M. Daley was appointed to the Compensation Committee and the Public Policy Committee of the Abbott Board of Directors. As previously reported on Abbott’s Current Report on Form 8-K filed October 15, 2004, Mr.... |
| 02 May 2002 |
8-K/A: Changes in Registrant's Certifying Accountant
Arthur Andersen LLP 33 West Monroe Street Chicago IL 60603-5385 Tel 312 580 0030 www.andersen.com |
| 01 Apr 2002 |
8-K/A: Changes in Registrant's Certifying Accountant
QuickLinks -- Click here to rapidly navigate through this document |
| 14 May 2001 |
8-K/A: Financial Statements and Exhibits
BASF PHARMACEUTICAL BUSINESS CONSOLIDATED STATEMENTS OF INCOME (EUROS IN MILLIONS) |
Loading...